{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:03Z","timestamp":1791389043679,"version":"4.3.3"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cld.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T20:43:30Z","timestamp":1448052210000},"page":"15-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The Immunogenetics of Autoimmune Cholestasis"],"prefix":"10.1016","volume":"20","author":[{"given":"Palak J.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon M.","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cld.2015.08.002_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2013.03.053","article-title":"The genetics of complex cholestatic disorders","volume":"144","author":"Hirschfield","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0031-1276647","article-title":"Deciphering the genetic predisposition to primary sclerosing cholangitis","volume":"31","author":"Karlsen","year":"2011","journal-title":"Semin Liver Dis"},{"issue":"2\u20133","key":"10.1016\/j.cld.2015.08.002_bib4","first-page":"154","article-title":"Genetics in PSC: what do the \u201crisk genes\u201d teach us?","volume":"48","author":"Folseraas","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.08.002_bib6","unstructured":"Charman S, Copley L, Tovikkai C, et\u00a0al. UK Liver Transplant Audit (NHS Blood and Transplant). 2012. Available at: https:\/\/www.rcseng.ac.uk\/surgeons\/research\/surgical-research\/docs\/liver-transplant-audit-report-2012. Accessed July 21, 2015."},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2005\/203028","article-title":"Characteristics of primary biliary cirrhosis in British Columbia\u2019s First Nations population","volume":"19","author":"Arbour","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group","volume":"36","author":"Watson","year":"1995","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12072-012-9362-7","article-title":"Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments","volume":"7","author":"Trivedi","year":"2013","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clinre.2011.10.007","article-title":"PSC, AIH and overlap syndrome in inflammatory bowel disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2015.08.002_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"De Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.cld.2015.08.002_bib17","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.cld.2015.08.002_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/hep.24414","article-title":"Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving","volume":"54","author":"Invernizzi","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2015.08.002_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib27","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2015.08.002_bib28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/liv.12492","article-title":"Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease","volume":"34","author":"Naess","year":"2014","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/j.gastro.2011.05.048","article-title":"HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn\u2019s disease","volume":"141","author":"Okada","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2010.02.030","article-title":"PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival","volume":"53","author":"Rudolph","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2015.08.002_bib33","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.08.002_bib34","article-title":"Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists","author":"Trivedi","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2015.01.041","article-title":"Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis","volume":"148","author":"Berntsen","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib36","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased Th17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib37","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.002_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","article-title":"The role of natural killer cells in autoimmune liver disease: a comprehensive review","volume":"46","author":"Hudspeth","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T\u00a0regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2015.08.002_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","article-title":"Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2R\u03b1(-\/-) mice","volume":"51","author":"Yao","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2015.08.002_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","article-title":"Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features","volume":"18","author":"Filipe-Santos","year":"2006","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.cld.2015.08.002_bib45","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2015.08.002_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.23667","article-title":"Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction","volume":"52","author":"Juran","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","article-title":"Inflammatory pathways in liver homeostasis and liver injury","volume":"36","author":"Tacke","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/gene.2013.1","article-title":"Pathway-based analysis of primary biliary cirrhosis genome-wide association studies","volume":"14","author":"Kar","year":"2013","journal-title":"Genes Immun"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1746.2002.02672.x","article-title":"Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis","volume":"17","author":"Neuman","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.24085","article-title":"Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity","volume":"53","author":"Liaskou","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00281-009-0157-4","article-title":"Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners","volume":"31","author":"Steinberg","year":"2009","journal-title":"Semin Immunopathol"},{"issue":"7214","key":"10.1016\/j.cld.2015.08.002_bib56","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria T(H)17 cell differentiation","volume":"455","author":"Atarashi","year":"2008","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J\u00a0Exp Med"},{"issue":"7357","key":"10.1016\/j.cld.2015.08.002_bib58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10228","article-title":"Control of TH17 cells occurs in the small intestine","volume":"475","author":"Esplugues","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cld.2015.08.002_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/mi.2009.113","article-title":"CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles","volume":"2","author":"Marchesi","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","article-title":"CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"13","key":"10.1016\/j.cld.2015.08.002_bib64","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood-2012-06-434779","article-title":"IL-7 induces expression and activation of integrin \u03b14\u03b27 promoting naive T-cell homing to the intestinal mucosa","volume":"120","author":"Cimbro","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib65","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib66","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ibd.22974","article-title":"IL-10R polymorphisms are associated with very-early-onset ulcerative colitis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"7405","key":"10.1016\/j.cld.2015.08.002_bib69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-\/- mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib70","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2010.01.005","article-title":"Regulation of plasmacytoid dendritic cell development","volume":"22","author":"Reizis","year":"2010","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib71","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.it.2009.03.002","article-title":"CARD9 versus CARMA1 in innate and adaptive immunity","volume":"30","author":"Hara","year":"2009","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib72","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.gastro.2013.05.047","article-title":"Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice","volume":"145","author":"Sokol","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2010.03.007","article-title":"T\u00a0cell receptor \u201cinside-out\u201d pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes","volume":"32","author":"Raab","year":"2010","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cld.2015.08.002_bib74","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/emboj.2009.82","article-title":"Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes","volume":"28","author":"Katagiri","year":"2009","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/gene.2011.88","article-title":"Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease","volume":"13","author":"H\u00e4user","year":"2012","journal-title":"Genes Immun"},{"issue":"20","key":"10.1016\/j.cld.2015.08.002_bib76","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1158\/0008-5472.CAN-06-0732","article-title":"Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases","volume":"66","author":"Lee","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib77","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"47","key":"10.1016\/j.cld.2015.08.002_bib78","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","article-title":"Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (secretor) genotype","volume":"108","author":"Rausch","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.cld.2015.08.002_bib79","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/apt.12663","article-title":"Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis","volume":"39","author":"Rupp","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2015.08.002_bib80","doi-asserted-by":"crossref","first-page":"e35307","DOI":"10.1371\/journal.pone.0035307","article-title":"Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the polish population","volume":"7","author":"Gaj","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib81","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9408","key":"10.1016\/j.cld.2015.08.002_bib82","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib83","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.08.002_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2012.12.008","article-title":"Y\u00a0chromosome loss in male patients with primary biliary cirrhosis","volume":"41","author":"Lleo","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Lleo","year":"2015","journal-title":"Clin Epigenetics"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J\u00a0Autoimmun"},{"issue":"10","key":"10.1016\/j.cld.2015.08.002_bib89","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.4049\/jimmunol.172.10.6388","article-title":"Ectopic CD40 ligand expression on B cells triggers intestinal inflammation","volume":"172","author":"Kawamura","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MOG.0b013e32834d0844","article-title":"Advances in coeliac disease","volume":"28","author":"Armstrong","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2015.08.002_bib91","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1172\/JCI59255","article-title":"Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis","volume":"121","author":"Lee","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"2\u20133","key":"10.1016\/j.cld.2015.08.002_bib92","first-page":"176","article-title":"Genetics in PBC: what do the \u201crisk genes\u201d teach us?","volume":"48","author":"Hirschfield","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.cld.2015.08.002_bib93","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2015.08.002_bib94","doi-asserted-by":"crossref","first-page":"436450","DOI":"10.1155\/2015\/436450","article-title":"Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases","volume":"2015","author":"Zhang","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib95","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/iid3.34","article-title":"Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex\u00ae","volume":"2","author":"Heninger","year":"2014","journal-title":"Immun Inflamm Dis"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib96","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/apt.12639","article-title":"Review article: anti-adhesion therapies for inflammatory bowel disease","volume":"39","author":"Lobat\u00f3n","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2015.08.002_bib97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000109937","article-title":"Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12\/23p40 in a nonhuman primate model of multiple sclerosis","volume":"5","author":"Hart","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"2","key":"10.1016\/j.cld.2015.08.002_bib98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/08923973.2014.890626","article-title":"Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials","volume":"36","author":"Hassan","year":"2014","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib99","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A\u00a0phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cld.2015.08.002_bib100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","article-title":"CXCL13 antibody for the treatment of autoimmune disorders","volume":"16","author":"Klimatcheva","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.cld.2015.08.002_bib101","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/ncomms3479","article-title":"ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48","volume":"4","author":"Ha","year":"2013","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.cld.2015.08.002_bib102","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/tpj.2012.36","article-title":"Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma","volume":"13","author":"Berce","year":"2013","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib103","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2010.06.091","article-title":"Expression of functional GPR35 in human iNKT cells","volume":"398","author":"Fallarini","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.cld.2015.08.002_bib104","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/ng.489","article-title":"Common variants at five new loci associated with early-onset inflammatory bowel disease","volume":"41","author":"Imielinski","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cld.2015.08.002_bib105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/jpet.112.198945","article-title":"Antagonists of GPR35 display high species ortholog selectivity and varying modes of action","volume":"343","author":"Jenkins","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.cld.2015.08.002_bib106","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-09-1145","article-title":"A\u00a0novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Harikumar","year":"2010","journal-title":"Mol Cancer Ther"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T19:07:05Z","timestamp":1567364825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1089326115000744"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Immunogenetics of Autoimmune Cholestasis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}